cell therapy

Businessman about to be crushed by falling dominos

Fierce Pharma

BioNTech to wind down cell therapy manufacturing in Maryland

After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.

Fraiser Kansteiner Jun 18, 2025 10:23am

pendulum silver metallic spheres on coloured background with drop shadow

As investors pivot from cell therapy, Immatics keeps the faith

Jun 6, 2025 3:50am

embryonic stem cells

ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma

May 31, 2025 8:00am

Terminated contract

NIH nixes financing for Pluri's radiation exposure cell therapy

Apr 18, 2025 9:10am

too many options

Adaptimmune questions own longevity, axes preclinical funding

Mar 20, 2025 2:04pm

Yellow arrow going opposite direction as white arrows

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

Mar 20, 2025 9:11am